- Disease: Post-COVID-19
- Study type: Randomised Clinical Trial
- Study type descriptors: Interventional
- Study aim: To investigate the impact of methylprednisolone on cognitive deficits in patients with post-COVID-19 syndrome. To evaluate improvement in memory function in patients treated with methylprednisolone compared with placebo
- Number of participants enrolled: Enrollment ongoing
- Study enrolling from to
- Study includes follow-up for 5 months
Study Data
- Adults
- Elderly
- General population
- SARS-CoV-2
- Post-COVID-19
- Pharmacological intervention
- Corticosteroid
- Methylprednisolone
External Links
Other information
Funders:
- Charite University, Berlin, Germany
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to